EVALUATION OF THE EFFECTIVENESS OF COMBINED TREATMENT OF DIFFERENTIATED THYROID CANCER

TILLYASHAYXOV Mirzagaleb Nigmatovich, MALIKOV Muzaffar Abduvaxobovich

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2025-yil

Annotatsiya

 The study evaluated the effectiveness of combined treatment for differentiated thyroid cancer (DTC) considering morphological and molecular-genetic characteristics. A total of 300 patients treated at the Tashkent Branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology (2014–2024) were included. The use of an improved algorithm (ultrasound, FNAB, molecular testing, and personalized surgery) resulted in higher two-year recurrence-free survival (78.1% vs. 66.5%; p=0.033). Unfavorable prognostic mutations included TERT, RAS, PAX8-PPAR-γ, and BRAF-V600E. Extended thyroidectomy with lymph node dissection reduced recurrence risk. Integration of molecular profiling improved survival and reduced treatment costs.

Maqola ma’lumotlari
MualliflarTILLYASHAYXOV Mirzagaleb Nigmatovich, MALIKOV Muzaffar Abduvaxobovich
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
Nashr sanasi2025-11-25
Jild10
Son5
TilRus

Kalit so‘zlar

дифференцированный рак щитовидной железы, комбинированное лечение, молекулярно-генетический анализ, таргетная терапия, хирургия, прогноз, персонализированный подход, differentiated thyroid cancer, combined treatment, molecular-genetic analysis, targeted therapy, surgery, prognosis, personalized approach, differensiallashgan qalqonsimon bez saratoni, kombinasiyalashgan davolash, molekulyar-genetik tahlil, target terapiya, jarrohlik, prognoz, personallashtirilgan yondashuv

Ilmiy soha

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar